XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:              
Net loss $ (2,290,000) $ (672,000) $ (1,040,000) $ (1,136,000) $ (3,567,000) $ (3,159,000)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Bad debt recovery         (18,000) 0  
Non-cash lease expense from right-of-use asset         0 17,000  
Stock-based compensation         84,000 62,000  
Non-cash revenue from digital assets         (99,000) 0  
Unrealized loss on digital assets 1,517,000   0   1,486,000 0  
Changes in operating assets and liabilities:              
Accounts receivable         192,000 391,000  
Inventory         0 189,000  
Prepaid expenses and other current assets         (158,000) (40,000)  
Other assets         2,000 4,000  
Accounts payable         57,000 (118,000)  
Accrued expenses and other current liabilities         (238,000) 254,000  
Deferred revenue         (12,000) (104,000)  
Lease liabilities         0 (17,000)  
Net cash used in operating activities         (2,271,000) (2,521,000)  
Cash flows from investing activities:              
Purchases of digital assets         (8,000,000) 0  
Net cash used in investing activities         (8,000,000) 0  
Cash flows from financing activities:              
Proceeds from private placement, net of issuance costs         6,888,000 0  
Net cash provided by financing activities         9,043,000 2,150,000  
Decrease in cash         (1,228,000) (371,000)  
Cash and cash equivalents at beginning of period   $ 4,965,000   $ 5,990,000 4,965,000 5,990,000 $ 5,990,000
Cash and cash equivalents at end of period 3,737,000   5,619,000   3,737,000 5,619,000 4,965,000
Reconciliation of cash and cash equivalents              
Cash 3,237,000   5,119,000   3,237,000 5,119,000  
Current certificates of deposit 500,000   500,000   500,000 500,000 500,000
Total cash and cash equivalents 3,737,000   5,619,000   3,737,000 5,619,000 4,965,000
Cash paid during the period for interest         1,000 0  
Non-cash investing and financing activities:              
Common warrant issuance         335,000 0  
Series F Preferred Stock conversion         39,000 194,000  
Dividends, Preferred Stock         29,000 76,000  
Warrants, deemed dividend 0   $ 8,974,000   0 8,974,000 $ 8,974,000
Common Stock Warrants [Member]              
Cash flows from financing activities:              
Proceeds from exercise of common stock warrants, net of costs         1,639,000 672,000  
Preferred Warrants [Member]              
Cash flows from financing activities:              
Proceeds from exercise of common stock warrants, net of costs $ 516,000       $ 516,000 $ 1,478,000